DE68914495T2 - Antihypercholesterolemisches Mittel. - Google Patents

Antihypercholesterolemisches Mittel.

Info

Publication number
DE68914495T2
DE68914495T2 DE68914495T DE68914495T DE68914495T2 DE 68914495 T2 DE68914495 T2 DE 68914495T2 DE 68914495 T DE68914495 T DE 68914495T DE 68914495 T DE68914495 T DE 68914495T DE 68914495 T2 DE68914495 T2 DE 68914495T2
Authority
DE
Germany
Prior art keywords
antihypercholesterolemic agent
antihypercholesterolemic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68914495T
Other languages
English (en)
Other versions
DE68914495D1 (de
Inventor
Henry Joshua
Michael S Schwartz
Kenneth E Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE68914495D1 publication Critical patent/DE68914495D1/de
Publication of DE68914495T2 publication Critical patent/DE68914495T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE68914495T 1988-03-02 1989-02-23 Antihypercholesterolemisches Mittel. Expired - Lifetime DE68914495T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16278588A 1988-03-02 1988-03-02

Publications (2)

Publication Number Publication Date
DE68914495D1 DE68914495D1 (de) 1994-05-19
DE68914495T2 true DE68914495T2 (de) 1994-10-27

Family

ID=22587122

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68914495T Expired - Lifetime DE68914495T2 (de) 1988-03-02 1989-02-23 Antihypercholesterolemisches Mittel.

Country Status (6)

Country Link
US (1) US4968693A (de)
EP (1) EP0331250B1 (de)
JP (1) JPH023623A (de)
KR (1) KR910000695A (de)
CA (1) CA1328878C (de)
DE (1) DE68914495T2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059696A (en) * 1990-03-15 1991-10-22 Merck & Co., Inc. Processes and intermediates for the preparation of 5-oxygenated hmg-coa reductase inhibitors
EP1133281A1 (de) 1998-11-20 2001-09-19 RTP Pharma Inc. Dispergierbare mit phospholipid stabilisierte mikropartikel
JP2003513036A (ja) * 1999-11-03 2003-04-08 ハワード ジェイ．スミス アンド アソシエイツ ピーティーワイ リミテッド 肝臓選択的な治療方法
BR0108077A (pt) 2000-02-04 2002-10-22 Children S Hospital Res Founda Processo para reduzir placas ateroscleróticas em um mamìfero, método para tratamento da aterosclerose em um mamìfero, composição, métodos para prover proteìna ou polipeptìdeo hidrolisante de lipìdeo biologicamente ativo ou mistura deles, para células de um mamìfero tendo deficiência na proteìna ou polipeptìdeo hidrolisante de lipìdeo biologicamente ativo , para prover lipase de ácido lisossomal biologicamente ativa para células de um mamìfero tendo deficiência de lipase de ácido lisossomal biologicamente ativa, para prover lipase de ácido lisossoal biologicamente ativa para células de um mamìfero com aterosclerose, para tratamento da doença de wolman em um mamìfero, para tratamento de doença de armazenagem de colesteril éster em um mamìfero, e, para tratamento da aterosclerose em um mamìfero
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
AU2003209990B8 (en) * 2002-02-25 2008-10-30 Kudos Pharmaceuticals Ltd Pyranones useful as ATM inhibitors
PT3072978T (pt) 2002-05-09 2018-10-15 Brigham & Womens Hospital Inc 1l1rl-1 como um marcador de doença cardiovascular
US9492388B2 (en) 2002-12-20 2016-11-15 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
EP1510208A1 (de) * 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Metformin-Statin-Kombination enthaltende pharmazeutische Zusammensetzungen
US7803838B2 (en) * 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
AU2005294165B2 (en) 2004-10-06 2012-02-02 The Brigham And Women's Hospital, Inc. Relevance of achieved levels of markers of systemic inflammation following treatment
CA2596426A1 (en) * 2005-01-31 2006-08-10 Mylan Laboratories, Inc. Pharmaceutical composition comprising hydroxylated nebivolol
JP2008545742A (ja) 2005-05-31 2008-12-18 マイラン ラボラトリーズ インク． ネビボロールを含む組成物
US8119358B2 (en) 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
CA2659082A1 (en) 2006-06-07 2007-12-21 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
WO2008026702A1 (en) 2006-08-30 2008-03-06 Kyushu University, National University Corporation Pharmaceutical composition containing statin-encapsulated nanoparticle
BRPI0810409A2 (pt) 2007-04-18 2015-02-18 Thethys Bioscience Inc Biomarcadores relacionados ao diabetes e métodos de uso destes
CA2788571A1 (en) 2010-02-01 2011-08-04 Andrew Redington Remote ischemic conditioning for treatment and prevention of restenosis
US20110240043A1 (en) 2010-03-31 2011-10-06 The Hospital For Sick Children Use of remote ischemic conditioning to improve outcome after myocardial infarction
AU2011237461B2 (en) 2010-04-08 2015-11-26 The Hospital For Sick Children Use of remote ischemic conditioning for traumatic injury
ES2786506T3 (es) 2012-08-01 2020-10-13 Zahra Tavakoli Composiciones congeladas fluidas que comprenden un agente terapéutico
SG11201507751YA (en) 2013-03-21 2015-10-29 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
AU2016343952A1 (en) 2015-10-27 2018-05-10 Eupraxia Pharmaceuticals Inc. Sustained release formulations of local anesthetics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
JPS59186972A (ja) * 1983-03-09 1984-10-23 Suntory Ltd オクタヒドロナフタレン誘導体並びにその製造法
US4582915A (en) * 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
US4833258A (en) * 1987-02-17 1989-05-23 Merck & Co., Inc. Intermediates useful in the preparation of HMG-COA reductase inhibitors
US4857522A (en) * 1988-03-21 1989-08-15 E. R. Squibb & Sons, Inc. Derivatives of pravastatin for inhibiting cholesterol biosynthesis

Also Published As

Publication number Publication date
US4968693A (en) 1990-11-06
EP0331250A2 (de) 1989-09-06
CA1328878C (en) 1994-04-26
KR910000695A (ko) 1991-01-30
JPH023623A (ja) 1990-01-09
DE68914495D1 (de) 1994-05-19
EP0331250B1 (de) 1994-04-13
EP0331250A3 (en) 1990-05-16

Similar Documents

Publication Publication Date Title
ATE103278T1 (de) Fungizides mittel.
DE68914495D1 (de) Antihypercholesterolemisches Mittel.
DE58905119D1 (de) Heteroaryloxyessigsaeure-n-isopropylanilide.
DE68907927D1 (de) Bedienungsvorrichtung.
NO892617D0 (no) Anti-aterogene midler.
DE68903708T2 (de) Spielkasten.
DE69003121D1 (de) Filmbildendes Mittel.
DE58902774D1 (de) Pflanztafel.
FI880299A0 (fi) Truck.
DE68915269T2 (de) Polyvalentes entzündungshemmendes mittel.
DE58902346D1 (de) Traenkeventil.
NO893141D0 (no) Toey-kondisjoneringsmidler.
ATE100094T1 (de) Imidazolantiarrythmische mittel.
DE68910299D1 (de) Brotaufstrich.
DE68901775T2 (de) Mammographiegeraet.
DE58902190D1 (de) Schaelmaschine.
DE3761240D1 (de) Antihypoxisches mittel.
DE69006039T2 (de) Milbentötendes Mittel.
DE69004699T2 (de) Zahnreinigungsmittel.
DE68907244D1 (de) Anti-arteriosklerotisches mittel.
KR900000020U (ko) 콤바인 2번구 환원장치
DE58908380D1 (de) Benzofuranylbiphenyle.
DE68904912D1 (de) Ringlaser-kreisel.
DE58905260D1 (de) Mikrobizide mittel.
NO885622D0 (no) Tegnebords-tape.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee